Advanced Care Planning for Sarcoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve how patients with sarcoma, a type of cancer, prepare for future mobility needs after surgery. It uses a checklist to assist patients and their caregivers in planning for life post-surgery, whether the surgery involved limb-saving or limb removal. The goal is to enhance life quality by addressing how mobility changes might affect daily activities. This trial suits English-speaking patients who have undergone limb surgery for sarcoma within the last six months or have advanced sarcoma and are currently receiving treatment. Participants need computer access to complete the online checklist and must be able to provide informed consent. As an unphased trial, it offers a unique opportunity to contribute to research that could improve post-surgery planning and quality of life for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this advanced care planning checklist tool is safe for assessing mobility needs in sarcoma patients?
Research has shown that planning ahead for care, such as using a mobility needs checklist, is generally safe. Studies have found that these tools help patients prepare for future needs without causing harm. For instance, reviews indicate that planning ahead often leads to more home care instead of hospital stays, which can improve quality of life. No reports have linked negative effects directly to using these checklists, indicating they are well-tolerated. Participants can feel confident that using the checklist is safe.12345
Why are researchers excited about this trial?
Researchers are excited about the Advanced Care Planning (ACP) Mobility Checklist because it offers a novel approach to supportive care for sarcoma patients. Unlike traditional treatments that focus primarily on the physical aspects of the disease, this method emphasizes comprehensive care planning, which can enhance the patient’s quality of life and autonomy. By involving patients in a structured discussion about their care preferences and future health decisions, the checklist aims to empower them and potentially improve their overall healthcare experience. This holistic approach might address unmet needs in the current standard of care, which often overlooks the importance of individualized care planning.
What evidence suggests that the advanced care planning checklist is effective for assessing future mobility needs in sarcoma patients?
Research has shown that using a checklist for planning future care can improve the quality of life for patients with sarcoma. In this trial, participants will complete the Advance Care Planning (ACP) Mobility Checklist, which prepares them for future mobility needs. Studies of similar programs for cancer patients have found that planning ahead can lead to more care at home rather than in the hospital, allowing patients to spend more time in a comfortable setting. Additionally, clear communication and decision-making tools enhance the effectiveness of this planning. Overall, these strategies help patients make informed choices about their care.12567
Who Is on the Research Team?
Megan J Shen, PhD.
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 with sarcoma who've had limb surgery or are in active treatment for stage IV sarcoma. They must be able to consent and have computer access. Caregivers meeting the same criteria can also participate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants complete the Advance Care Planning (ACP) Mobility Checklist and associated questionnaires
Follow-up
Participants are monitored for changes in functional status, planning for mobility needs, and engagement in clinical conversations
What Are the Treatments Tested in This Trial?
Interventions
- Assessment
- Interview
- Questionnaire Administration
Assessment is already approved in United States, European Union for the following indications:
- Glioblastoma multiforme
- Refractory anaplastic astrocytoma
- Glioblastoma multiforme
- Refractory anaplastic astrocytoma
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor